Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139.
Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139.
Proc Natl Acad Sci U S A. 2020 Aug 18;117(33):20077-20087. doi: 10.1073/pnas.1919329117. Epub 2020 Aug 3.
Natural infections and vaccination with a pathogen typically stimulate the production of potent antibodies specific for the pathogen through a Darwinian evolutionary process known as affinity maturation. Such antibodies provide protection against reinfection by the same strain of a pathogen. A highly mutable virus, like HIV or influenza, evades recognition by these strain-specific antibodies via the emergence of new mutant strains. A vaccine that elicits antibodies that can bind to many diverse strains of the virus-known as broadly neutralizing antibodies (bnAbs)-could protect against highly mutable pathogens. Despite much work, the mechanisms by which bnAbs emerge remain uncertain. Using a computational model of affinity maturation, we studied a wide variety of vaccination strategies. Our results suggest that an effective strategy to maximize bnAb evolution is through a sequential immunization protocol, wherein each new immunization optimally increases the pressure on the immune system to target conserved antigenic sites, thus conferring breadth. We describe the mechanisms underlying why sequentially driving the immune system increasingly further from steady state, in an optimal fashion, is effective. The optimal protocol allows many evolving B cells to become bnAbs via diverse evolutionary paths.
自然感染和病原体疫苗接种通常通过达尔文进化过程刺激针对病原体的强效抗体的产生,这个过程称为亲和力成熟。这些抗体为同种病原体的再感染提供保护。像 HIV 或流感这样高度易变的病毒通过出现新的突变株来逃避这些针对特定菌株的抗体的识别。能够结合病毒许多不同株的抗体 - 称为广泛中和抗体(bnAbs)- 的疫苗可以预防高度易变的病原体。尽管做了很多工作,但 bnAbs 出现的机制仍不确定。我们使用亲和力成熟的计算模型研究了各种接种策略。我们的研究结果表明,通过顺序免疫方案最大限度地提高 bnAb 进化是一种有效的策略,其中每次新免疫都能优化免疫系统针对保守抗原位点的压力,从而提高广度。我们描述了为什么以最佳方式将免疫系统逐渐从稳态中驱动,从而有效地发挥作用的机制。最佳方案允许许多进化中的 B 细胞通过多种进化途径成为 bnAbs。